Nonmalignant late effects in survivors of partially matched donor hematopoietic stem cell transplantation.

@article{Mo2013NonmalignantLE,
  title={Nonmalignant late effects in survivors of partially matched donor hematopoietic stem cell transplantation.},
  author={X. Mo and L. Xu and D. Liu and X. Zhang and Huan Chen and Y. Chen and W. Han and Yu Wang and F. Wang and J. Wang and K. Liu and X. Huang},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2013},
  volume={19 5},
  pages={
          777-83
        }
}
  • X. Mo, L. Xu, +9 authors X. Huang
  • Published 2013
  • Medicine
  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • Human leukocyte antigen (HLA) partially matched related donor (PMRD) hematopoietic stem cell transplantation (HSCT) is an effective option for hematological malignancies. In this study, the nonmalignant late effects of PMRD HSCT were evaluated and compared with HLA-identical sibling donor (ISD) HSCT. Three hundred thirteen patients (ISD, n = 160; PMRD, n = 153) who survived at least 6 months and received regular follow-up examinations after their HSCT were enrolled. The 5-year cumulative… CONTINUE READING
    8 Citations
    Late‐onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatments
    • X. Mo, X-h Zhang, +9 authors X-j Huang
    • Medicine
    • Transplant infectious disease : an official journal of the Transplantation Society
    • 2016
    • 7
    Fighting against hematological malignancy in China: from unique system to global impact
    • 9
    • PDF

    References

    SHOWING 1-10 OF 38 REFERENCES
    [A clinical analysis of HLA-identical hematopoietic stem cell transplantation for severe aplastic anemia.].
    • 3
    Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
    • 288
    • PDF
    Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
    • N. Khera, B. Storer, +5 authors S. Lee
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2012
    • 68
    • Highly Influential
    Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    • X. Huang, D. Liu, +6 authors D. Lu
    • Medicine
    • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
    • 2009
    • 234
    Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    • A. Bacigalupo, T. Lamparelli, +9 authors A. Bosi
    • Medicine
    • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
    • 2006
    • 266
    Heart failure after allogeneic hematopoietic stem cell transplantation.
    • 6